Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients

Jeeyun Lee, Su Jin Lee, Jongtae Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Kyoung Mee Kim, In Gu Do, Sin Ho Jung, Dong Seok Yim, Won Ki Kang

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences